MedTrace Logo

MSFC Versus DAM. A Smartphone Application for Multiple Sclerosis Self-assessment.

NCT02814487 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2016-09-12

No results posted yet for this study

Summary

Multiple Sclerosis Functional Composite score (MSFC) is one of the gold standard for multiple sclerosis (MS) patient clinical evaluation. However, its practical implementation is not always optimal as it can prove to be very time consuming. Moreover, it often constrains the range of tests used and is not a particularly good marker for patient real life disability status.

A mobile application called Digital Self-Assessment for Multiple Sclerosis (DAM) was developed in order to replicate each of MSFC tests available in order to assess MS progression in the patient environment.

Conditions

Sponsors & Collaborators

  • Roche Pharma AG

    collaborator INDUSTRY

  • Ad scientiam

    lead OTHER

Principal Investigators

  • Elisabeth MAILLARD, MD · Pitié Salpêtrière Hospital, Paris

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2016-09-30
Completion
2016-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02814487 on ClinicalTrials.gov